£75.52

About as cheap as it gets — within 5% of the all-time low it hit 1 month ago.

£76 today · all-time low £74 (Sep 2026) · usually £74

Springer Lung Cancer Personalized Medicine - Novel Therapies & Clinical Management

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 68 days · 68 data points (no recent data)

Historical
Generating forecast…
£76.42 £73.37 £74.04 £74.70 £75.37 £76.03 £76.70 23 July 2026 08 August 2026 25 August 2026 11 September 2026 28 September 2026
View at Amazon ↗

Price data last checked 23 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 68 days • 3 price levels

Days at Price
Current Price
16 days 2 days 50 days 0 13 25 38 50 £74 £75 £76 Days at Price

Price Analysis

Most common price: £76 (50 days, 73.5%)

Price range: £74 - £76

Price levels: 3 different prices over 68 days

Description

This second volume in the Advances in Experimental Medicine and Biology series examines personalized approaches to lung cancer treatment, covering targeted drug development informed by genomic analysis, emerging biomarkers and therapeutic targets including EMT and cancer stem cells, tumour microenvironment dynamics, and current clinical management strategies with radiation therapy options. The book explores how epigenetics and next-generation sequencing technologies are advancing personalised therapy protocols for lung cancer patients, featuring expert contributions on state-of-the-art therapies and innovations from leading researchers developing novel clinical applications.

Key Features

Springer's volume 890 in the Advances in Experimental Medicine and Biology series focuses on personalised medicine approaches for lung cancer patients.

Comprehensive coverage of targeted drug development strategies based on genomic analysis and molecular profiling for precision oncology.

Expert chapters on emerging biomarkers, therapeutic targets, EMT mechanisms, cancer stem cells, and tumour microenvironment interactions in lung cancer.

Current clinical management protocols and radiation therapy techniques integrated with personalised treatment planning for individual patients.

Explores epigenetics and next-generation sequencing technologies as tools for advancing personalised therapy outcomes in lung cancer care.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
30 March 2018
Listed Since
30 March 2018

Barcode

No barcode data available

Similar Products You Might Like

89% match

Progress in Lung Cancer Management (Experts' Perspectives on Medical Advances)

Springer

£129.99 15 Sep 2026
Molecular Targeted Therapy of Lung Cancer
88% match

Molecular Targeted Therapy of Lung Cancer

Springer

£113.79 08 Aug 2026
Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)
86% match

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

£66.33 05 Aug 2026
Precision Medicine in Cancer Therapy: 178 (Cancer Treatment and Research, 178)
86% match

Precision Medicine in Cancer Therapy: 178 (Cancer Treatment and Research, 178)

Springer

£61.57 15 Sep 2026
Precision Medicine in Cancer Therapy: 178 (Cancer Treatment and Research, 178)
86% match

Precision Medicine in Cancer Therapy: 178 (Cancer Treatment and Research, 178)

Springer

£88.21 17 Aug 2026
Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice
86% match

Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice

Springer

£80.67 05 Aug 2026
Management des Lungenkarzinoms (Onkologie aktuell)
85% match

Management des Lungenkarzinoms (Onkologie aktuell)

Springer

£76.48 14 Sep 2026
Advancements in Clinical Research: 952 (Advances in Experimental Medicine and Biology, 952)
85% match

Advancements in Clinical Research: 952 (Advances in Experimental Medicine and Biology, 952)

Springer

£76.42 14 Sep 2026
Lung Cancer and Autoimmune Disorders: 833 (Advances in Experimental Medicine and Biology, 833)
84% match

Lung Cancer and Autoimmune Disorders: 833 (Advances in Experimental Medicine and Biology, 833)

Springer

£76.42 07 Aug 2026
Lung Cancer and Autoimmune Disorders: 833 (Advances in Experimental Medicine and Biology, 833)
84% match

Lung Cancer and Autoimmune Disorders: 833 (Advances in Experimental Medicine and Biology, 833)

Springer

£76.42 05 Aug 2026
Management of Lung Cancer in Older People
84% match

Management of Lung Cancer in Older People

Springer

£103.27 04 Aug 2026
Biology and Management of Lung Cancer: 11 (Cancer Treatment and Research)
84% match

Biology and Management of Lung Cancer: 11 (Cancer Treatment and Research)

Springer

£169.56 06 Aug 2026
Current Topics in Lung Cancer (ESO Monographs)
84% match

Current Topics in Lung Cancer (ESO Monographs)

Springer

£77.90 15 Sep 2026
Molecular Imaging in Oncology - Volume 2: Advanced Solutions to Acquire Disease-Specific Biomarkers - Clinical Applications (Recent Results in Cancer Research, 225)
83% match

Molecular Imaging in Oncology - Volume 2: Advanced Solutions to Acquire Disease-Specific Biomarkers - Clinical Applications (Recent Results in Cancer Research, 225)

Springer

£149.04 31 Aug 2026
Novel Biomarkers in Non-Small Cell Lung Cancer (NSCLC)
83% match

Novel Biomarkers in Non-Small Cell Lung Cancer (NSCLC)

£62.49 29 Sep 2026
The Molecular Genetics of Lung Cancer
83% match

The Molecular Genetics of Lung Cancer

Springer

£80.67 15 Oct 2026
Cancer of the Lung: From Molecular Biology to Treatment Guidelines (Current Clinical Oncology)
83% match

Cancer of the Lung: From Molecular Biology to Treatment Guidelines (Current Clinical Oncology)

Humana

£108.01 06 Aug 2026
Targeted Therapies for Lung Cancer (Current Cancer Research)
83% match

Targeted Therapies for Lung Cancer (Current Cancer Research)

Springer

£92.22 05 Aug 2026
Management of Lung Cancer in Older People
83% match

Management of Lung Cancer in Older People

Springer

£80.67 04 Aug 2026
Gene-Based Therapies for Cancer (Current Cancer Research)
83% match

Gene-Based Therapies for Cancer (Current Cancer Research)

Springer

£108.01 06 Aug 2026
Advances in Biology and Therapy of Multiple Myeloma: Volume 2: Translational and Clinical Research
83% match

Advances in Biology and Therapy of Multiple Myeloma: Volume 2: Translational and Clinical Research

Springer

£108.01 06 Aug 2026
Impact of Genetic Targets on Cancer Therapy: 779 (Advances in Experimental Medicine and Biology, 779)
82% match

Impact of Genetic Targets on Cancer Therapy: 779 (Advances in Experimental Medicine and Biology, 779)

Springer

£119.13 18 Aug 2026
Lung Cancer: Basic and Clinical Aspects: Basic and Clinical Aspects: 28 (Cancer Treatment and Research, 28)
82% match

Lung Cancer: Basic and Clinical Aspects: Basic and Clinical Aspects: 28 (Cancer Treatment and Research, 28)

Springer

£124.47 15 Sep 2026
Personalised Medicine: Lessons from Neurodegeneration to Cancer: 1007 (Advances in Experimental Medicine and Biology, 1007)
82% match

Personalised Medicine: Lessons from Neurodegeneration to Cancer: 1007 (Advances in Experimental Medicine and Biology, 1007)

Springer

£116.46 27 Aug 2026